ViiVHealthcare US

You are about to leave ViiVMedinfo.
 

By clicking "Allow," you will be taken to a website that is independent of ViiV Healthcare. The site you linking to is not controlled or endorsed by ViiV Healthcare, and ViiV Healthcare is not responsible for the content provided on that site.

This site is intended for US healthcare professionals only.

  • HIV Prevention
  • HIV Treatment
  • Pediatric HIV
  • Report an Adverse Event
ViiVHealthcare
  • Home
  • Congress Presentations
  • HIV Resources
    • HIV Prevention
    • HIV Treatment
    • Pediatric HIV
    • Videos and Events
    • Medical Resources
  • Our HIV Medicines
  • Our Pipeline
  • Connect With Us
    • Our HIV Experts
    • Connect With Us
ViiVHealthcare
  • Home
  • Congress Presentations
  • HIV Resources
    • HIV Prevention
    • HIV Treatment
    • Pediatric HIV
    • Videos and Events
    • Medical Resources
  • Our HIV Medicines
  • Our Pipeline
  • Connect With Us
    • Our HIV Experts
    • Connect With Us
Our HIV Medicines
Show Medicines
Hide Medicines
OUR HIV MEDICINES
  • Apretude
  • Cabenuva
  • Dovato
  • Tivicay / Tivicay PD
  • Juluca
  • Rukobia
  • Triumeq / Triumeq PD
  • Vocabria
  • Combivir
  • Epivir
  • Epzicom
  • Retrovir
  • Selzentry
  • Lexiva
  • Trizivir
  • Viracept
  • Ziagen

Tivicay / Tivicay PD

(dolutegravir)

TIVICAY and TIVICAY PD are a HIV-1 integrase strand transfer inhibitor (INSTI).

Prescribing Information

Patient Information

Talk to a Medical Expert

  • Medical Information Documents

    • Data in Pediatrics

      Use of Tivicay in Pediatric Patients

      Tivicay PD (MI letter)

      Tivicay PD Overview (Infographic)

    • Resistance Data

      Treatment-Emergent Resistance in Treatment-Naïve Patients

    • Safety Data

      Occurrence of Neural Tube Defects (MI letter)

      Maternal and Infant Outcomes During Pregnancy

      Psychiatric Events

      Effect on Renal Function

    • Weight Gain

      Weight Gain Overview

      Clinical Trial Data (Infographic)

    • Drug-Drug Interactions and Absorption

      Metabolism of and Drug Interactions with Tivicay

      Use with Tecovirimat

      Administration via NG Tube Feeding

    • Storage and Stability

      Splitting/Crushing

      Expiration, Repackaging, and Storage Conditions (MI letter)

      Expiration, Partial Dispensing, Unit-Dose, and Temp Stability (Infographic)

  • On Demand Medical Videos

    • Congress Data

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir
      DTG: Metabolic Data Update

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
      Post-CROI 2021 Webinar

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
    • Clinical Trials Data

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir
      Post-CROI 2021 Webinar

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
    • Dosing

      Tivicay PD: An Option for Children Living with HIV

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director
    • Pharmacokinetics

      Tivicay PD: An Option for Children Living with HIV

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director
    • Safety

      Post-CROI 2021 Webinar

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
      DTG: Metabolic Data Update

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
      Antiretroviral Therapy and Weight Gain

      Antiretroviral Therapy and Weight Gain

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      Antiretroviral Therapy and Weight Gain

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
    • Data in Pediatrics

      Tivicay PD (Video)

      Tivicay PD (Video)

      Tivicay PD (Video)

    • Weight Gain

      Weight Gain (Video)

      Weight Gain (Video)

      Weight Gain (Video)

      Metabolic Health (Video)

      Metabolic Health (Video)

      Metabolic Health (Video)

  • Talk to Medical Expert
  • Request a Scientific Discussion
  • Chat

Connect With Us

ViiVHealthcare US

Are you a US healthcare provider?
 

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
 

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
 

Yes

No

Connect With Our Medical Experts

Find My ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Talk to a Medical Expert

Connect now with a live ViiV Medical Expert.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1‑888‑226‑8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Our Response to COVID-19

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch

ViiVHealthcare US

This site is intended for US Healthcare Professionals Only. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

 

Trademarks are owned by or licensed to the ViiV Healthcare group of companies.

 

©2022 ViiV Healthcare group of companies or its licensor. Produced in USA. January 2022

  • Terms of Use
  • Cookie Policy
  • Privacy Notice
  • Terms and Conditions
  • ViiVHealthcare.com